Quantcast

Latest Amyloid Stories

2014-09-25 08:28:06

PHOENIX, Sept. 25, 2014 /PRNewswire/ -- NeuroEM Therapeutics, Inc., a Phoenix-based medical device R&D company, announced today that it has begun a study with a premiere research university to test its Transcranial Electromagnetic Treatment (TEMT) in aged primates. "All attempts to treat Alzheimer's through drugs have thus far been very disappointing, so our medical device represents a new therapeutic direction," said Dr. Gary Arendash, President and CEO of NeuroEM Therapeutics....

How Do Spiders Spin Silk?
2014-08-07 03:51:02

PLOS Spider silk is an impressive material; lightweight and stretchy yet stronger than steel. But the challenge that spiders face to produce this substance is even more formidable. Silk proteins, called spidroins, must convert from a soluble form to solid fibers at ambient temperatures, with water as a solvent, and at high speed. How do spiders achieve this astounding feat? In new research publishing in the open access journal PLOS Biology on August 5, Anna Rising and Jan Johansson show...

2014-07-17 16:26:33

MELBOURNE, Australia, July 17, 2014 /PRNewswire/ -- Prana Biotechnology (NASDAQ: PRAN; ASX: PBT) has today provided an update on its clinical development program for Alzheimer's disease. Professor Colin Masters, the Florey Institute of Neuroscience and Mental Health, The University of Melbourne, will today include data from Prana's Phase 2 IMAGINE and EURO trials in his presentation at the Alzheimer's Association International Conference in Copenhagen, Denmark. The presentation is...

Research Identifies Potential Cause Of Preeclampsia
2014-07-17 03:41:34

Nationwide Children's Hospital New research has identified a potential cause of and a better diagnostic method for preeclampsia, one of the most deadly and poorly understood pregnancy-related conditions in the world. The international team, led by researchers at Nationwide Children's Hospital, discovered that the disease may result from a collection of protein mishaps like those associated with Alzheimer's disease. Their findings, released today by Science Translational Medicine, have...

2014-07-15 12:28:31

Two drugs to be studied in North America and Europe in volunteers at high risk for disease COPENHAGEN, Denmark, July 15, 2014 /PRNewswire/ -- Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs--an active immunotherapy and an oral medication--can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for...

Research Opens Doors To Novel Alzheimer's Diagnosis Methods
2014-07-14 12:28:32

Brett Smith for redOrbit.com - Your Universe Online The confirmation of an Alzheimer’s diagnosis typically involves one of two procedures – a spinal tap or a brain-imaging scan. However, new research has opened the door to other possible methods – including a blood test, sense of smell exam or determining protein build-up in the eyes. Based in tests conducted on hundreds of patients, reports on the research are to be presented at the Alzheimer's Association International...

2014-07-13 12:20:48

Study Results Presented at the Alzheimer's Association International Conference 2014 INDIANAPOLIS, July 13, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced results from its non-clinical study in genetically engineered mice examining combination therapy with the murine version of the beta-amyloid antibody N3pG and beta-secretase inhibitor BACE (LY2811376). Data results found that combination therapy was more effective in removing clumps of amyloid-beta protein...

2014-07-11 13:26:52

IOS Press Monitoring formation of amylin plaques using 2-D IR spectroscopy, scientists have observed the creation of temporary intermediate structures, which may explain why proteins aggregate into toxic plaques Amyloid diseases, such as Alzheimer's disease, type 2 diabetes, cataracts, and the spongiform encephalopathies, all share the common trait that proteins aggregate into long fibers which then form plaques. Yet in vitro studies have found that neither the amylin monomer...

2014-05-28 08:26:44

- Preclinical data demonstrates reduction of Alzheimer's brain deficits to lower toxic Amyloid-beta and restored synaptic loss - PLANTATION, Fla., May 28, 2014 /PRNewswire/ -- Neurotrope, Inc. (OTCQB: NTRP) announced today the publication of positive human cell culture and mouse model data of Bryostatin 1 in two peer reviewed journals: PLOS One and the Journal of Pharmacology and Experimental Therapeutics. Neurotrope's lead drug candidate, Bryostatin 1, a potent activator of the...

2014-05-21 11:48:44

Saint Louis University A molecular compound developed by Saint Louis University scientists restored learning, memory and appropriate behavior in a mouse model of Alzheimer's disease, according to findings in the May issue of the Journal of Alzheimer's Disease. The molecule also reduced inflammation in the part of the brain responsible for learning and memory. The paper, authored by a team of scientists led by Susan Farr, Ph.D., research professor of geriatrics at Saint Louis University,...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related